Growth Horm IGF Res. 2025 Nov 17;83:101677. doi: 10.1016/j.ghir.2025.101677. Online ahead of print. ABSTRACT BACKGROUND: The safety and efficacy of somapacitan, a novel long-acting growth …
Int J Gynecol Cancer. 2025 Oct 21;36(1):102751. doi: 10.1016/j.ijgc.2025.102751. Online ahead of print. ABSTRACT OBJECTIVE: The World Health Organization (WHO) launched the Global Cervical Cancer …
Psychoneuroendocrinology. 2025 Nov 11;184:107685. doi: 10.1016/j.psyneuen.2025.107685. Online ahead of print. ABSTRACT Adverse Childhood Experiences (ACEs) are highly prevalent and associated to severe health outcomes in …
Immunohorizons. 2025 Nov 9;9(11):vlaf053. doi: 10.1093/immhor/vlaf053. ABSTRACT Autoreactive B cell activity defines the earliest detectable stage (Stage 1) of type 1 diabetes (T1D) but is …
Blood Adv. 2025 Nov 19:bloodadvances.2025016958. doi: 10.1182/bloodadvances.2025016958. Online ahead of print. ABSTRACT Sickle cell disease (SCD) is an understudied, life-threatening genetic disorder affecting around 300,000 …
N Engl J Med. 2025 Nov 20;393(20):2054-2057. doi: 10.1056/NEJMcibr2511327. NO ABSTRACT PMID:41259763 | DOI:10.1056/NEJMcibr2511327
JMIR Cancer. 2025 Nov 19;11:e76393. doi: 10.2196/76393. ABSTRACT BACKGROUND: About 40% of cancers are preventable through evidence-based interventions; however, uptake remains suboptimal. Knowledge and acceptance …
Educ Prim Care. 2025 Nov 19:1-5. doi: 10.1080/14739879.2025.2578790. Online ahead of print. ABSTRACT Assessment in UK General Practice (GP) training has traditionally relied on high-stakes …
JMIR Form Res. 2025 Nov 19;9:e79278. doi: 10.2196/79278. ABSTRACT BACKGROUND: Immersive technologies such as virtual reality, augmented reality, and mixed reality are used in pediatric …
Rheumatology (Oxford). 2025 Nov 19:keaf613. doi: 10.1093/rheumatology/keaf613. Online ahead of print. ABSTRACT OBJECTIVES: The progression of Behçet’s disease (BD) from a mucocutaneous-limited form to major …
